4.1 Nonhazardous CSP Handling, Labeling, Packaging, Storage, and Transport
Key Takeaways
- Handling, Packaging, Storage, and Disposal is worth 8% of the CSPT exam (about 5 of the 60 scored questions), the smallest of the four knowledge domains but heavily tested on temperature, labeling, and segregation logic.
- A finished nonhazardous CSP must be protected from contamination, mix-ups, temperature excursions, light, physical damage, and use beyond its beyond-use date (BUD); USP <797> assigns BUDs by sterility risk and storage condition.
- Storage status matters: released, quarantined, recalled, rejected, and expired CSPs must be physically or electronically separated so an at-risk product cannot be dispensed by mistake.
- Cold chain control means controlled room temperature 20-25 C (excursions 15-30 C), refrigeration 2-8 C, continuous or logged monitoring, alarm response, and validated transport packaging.
Why This Domain Matters
The CSPT exam (75 questions, 60 scored and 15 unscored, 1 hour 50 minutes of testing time, $149 exam fee plus a $50 application fee) devotes one domain to Handling, Packaging, Storage, and Disposal, weighted at 8% of the scored content. That is roughly 5 of the 60 scored questions — the smallest of the four domains, but a reliable source of points because the logic is rule-based, not judgment-heavy.
The exam angle is practical: once a sterile preparation leaves the engineering controls (the laminar-airflow or biological safety cabinet inside the ISO 7 buffer room), it can still harm a patient through bad labeling, wrong storage temperature, damaged packaging, or uncontrolled transport. USP General Chapter <797> governs sterile compounding and was republished effective November 1, 2023; the CSPT exam was updated the same day to reflect it.
Beyond-Use Date Drives Everything
The beyond-use date (BUD) is the date or time after which a CSP may not be used or transported. Under the 2023 <797>, BUDs are set by Category 1, Category 2, or Category 3 compounding and by storage temperature, not by the older low/medium/high-risk wording. A technician does not invent a BUD — it comes from the master formulation record or label. Your job is to preserve the conditions that the BUD assumed.
| Category | Typical room-temp BUD | Typical refrigerated BUD |
|---|---|---|
| Category 1 (segregated/limited controls) | ≤ 12 hours | ≤ 24 hours |
| Category 2 (ISO-classified, no sterility test) | up to 4 days | up to 10 days |
| Category 3 (extended, sterility + endotoxin tested) | up to 45 days | up to 60 days |
Labeling Checkpoints
A CSP label must make the preparation traceable and usable without guesswork. Facility policy controls the exact format, but exam scenarios expect patient or batch identification, drug name and amount, diluent or final concentration, route, storage requirements, BUD, and required auxiliary labels.
| Label item | Why it matters |
|---|---|
| Patient or batch identifier | Prevents mix-ups and supports recall tracing |
| Drug, strength, total volume, route | Allows final verification before dispensing |
| BUD and storage condition | Links use time to stability and sterility limits |
| Auxiliary warnings | Flags light protection, refrigeration, hazardous handling, or route restriction |
Packaging and Material Compatibility
Primary packaging touches the CSP directly: a syringe, vial, IV bag, cassette, or elastomeric pump. Secondary packaging protects the primary container, adds labeling space, and supports transport — overwraps, amber light-protective bags, sealed outer bags, tamper-evident closures, and cushioning.
Packaging is a compatibility decision, not a cosmetic one. Glass may be required when a drug adsorbs to plastic or is oxygen-sensitive. PVC (polyvinyl chloride) containers leach the plasticizer DEHP (di(2-ethylhexyl) phthalate), so drugs such as taxanes and some lipid products require PVC-free / DEHP-free tubing and bags. Latex-free supplies reduce allergy risk. A nitroglycerin IV in a standard PVC bag is a classic wrong setup — it adsorbs to PVC and loses potency.
Storage Status, Segregation, and FEFO
Finished CSPs awaiting release stay separated from CSPs released for dispensing. Quarantined, recalled, rejected, expired, or temperature-excursion products are held out of normal workflow until a pharmacist or approved procedure decides disposition. Rotate stock by FEFO (first expired, first out), not FIFO — the next item used is the one with the earliest BUD or expiration even if it arrived later.
Temperature and Cold Chain
Storage must match the label and stability data: controlled room temperature 20-25 C (transient excursions 15-30 C), refrigerated 2-8 C, and product-specific frozen ranges (commonly -25 to -10 C) that must not be guessed. Cold-chain control adds calibrated, monitored, alarmed refrigerators and freezers, excursion documentation, and quarantine of affected stock. A refrigerator failure is never fixed by relabeling — move stock to a working unit if policy allows, record the temperature history, quarantine, and escalate for stability review.
Finished CSP Transport
Internal transport may use sealed bins or bags; external delivery needs a validated shipper when time, temperature, or product status makes ordinary packaging unreliable. A transport record should identify the product, quantity, storage requirement, BUD, sender, recipient, time, and any temperature monitor or chain-of-custody need. On the exam, pick the answer that preserves sterility, stability, traceability, and segregation.
A refrigerated nonhazardous CSP shipment arrives with a temperature logger showing the package was above 8 C for an unknown period. What is the best next step?
Which inventory and storage practice best matches CSPT expectations for finished nonhazardous CSPs?
Exam Traps to Avoid
Do not treat packaging as a cosmetic step. A clear IV bag is wrong for a light-sensitive drug, and a standard PVC/DEHP set is wrong when the product requires PVC-free or DEHP-free materials. The hazard label or the BUD does not fix an incompatible container.
Do not confuse quarantine with disposal. Quarantine holds a product away from use while its status is investigated. Disposal happens only after a pharmacist, policy, recall instruction, or regulatory requirement determines the product cannot be used.
Do not assume all cold products tolerate ice or freezing. Refrigerated means 2-8 C; freezing a refrigerated CSP can cause precipitation, container cracking, or potency loss. And do not pick "dispense if the BUD has not passed" when a temperature history is unknown — the BUD only holds if storage conditions held. When two answers conflict, the one that preserves sterility, stability, and segregation is almost always correct.